Neurogene NGNE
NASDAQ NGNE
$26.14 +0.74 (+2.91%)
As of: Oct 21, 2026 · 1:24 PM EDT

Neurogene (NGNE) Total Debt (2013)

Updated

Neurogene (NGNE) reported Total Debt of $2.29 million for Q4 2013.

Analysis

Neurogene (NGNE) Total Debt (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,134.69 Bn 1,103.27 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 616.29 Bn 534.82 Bn 17.26 Bn 49.04 Bn
3 AbbVie 500.86 Bn 473.97 Bn 12.70 Bn 70.82 Bn
4 Merck 366.77 Bn 321.15 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn 32.35 Bn
7 Amgen 235.52 Bn 190.92 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 190.49 Bn 164.69 Bn 6.22 Bn 26.25 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 63.19 Bn
10 Neurogene 589.51 Mn -413.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 2.29 Mn
API Access

Neurogene Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NGNE&period=max&api_key=YOUR_API_KEY